Training in Vaccine Development

TRANSVAC is an infrastructure project – funded by the European Commission in the context of Horizon 2020 – that aims to accelerate the development of effective vaccines.

TRANSVAC2 offers high-quality training to students and professionals interested in vaccine R&D and manufacturing projects. 

Training scientists in vaccine research and development is crucial in order to sustain Europe’s excellence in this field. The TRANSVAC2 Consortium has set up training modules at leading European that can be combined to create customised international courses on vaccine R&D. Two rounds of customised training courses are planned. Participants can select topics as needed in their field of vaccine development, and the timelines of the various modules will be harmonised enabling a logical continuation from one topic to the other.

Open Applications:

M10 - Assay Development and Validation-Application of SPR Technologies in Vaccine development and manufacturing

Venue: Fraunhofer IME, Aachen Germany
Dates: 10-11 October 2019

M11 - Process Development and scale-up of recombinant protein vaccines

Venue: Fraunhofer IME, Aachen Germany
Dates: 7-8 October 2019

M12 - Requirements for GMP production 

Venue: Fraunhofer IME, Aachen Germany
Dates: 14-15 October 2019

Submission deadline: 1 July 2019 
Applicants can apply for all training via one application form!
Notification of application outcome: 1st August 2019
More information on the call and the application form can be found here.

For training related information, please contact the TRANSVAC team (transvacinfo@euvaccine.eu).